Liposomal amphotericin B therapy of murine histoplasmosis.

AUTOR(ES)

Graybill, J R

RESUMO

Liposomal amphotericin B (AmBisome) was compared with amphotericin B deoxycholate for the treatment of disseminated murine histoplasmosis. Liposomal amphotericin B was well tolerated and, milligram for milligram, was as potent as amphotericin B deoxycholate.

Documentos Relacionados

• Single-Dose AmBisome (Liposomal Amphotericin B) as Prophylaxis for Murine Systemic Candidiasis and Histoplasmosis
• Effect of liposomal amphotericin B on murine macrophages and lymphocytes.
• Clearance of Fungal Burden during Treatment of Disseminated Histoplasmosis with Liposomal Amphotericin B versus Itraconazole
• Efficacy of Liposomal Amphotericin B in Treatment of Systemic Murine Fusariosis
• Experiments on lymphocyte-mediated cellular immunity in murine histoplasmosis.